APA (7th ed.) Citation

MV, B., BT, M., EF, S., KA, M., E, A., & WD, K. (2019). Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. Antimicrobial agents and chemotherapy, 63(6), . https://doi.org/10.1128/AAC.00110-19

Chicago Style (17th ed.) Citation

MV, Beccari, Mogle BT, Sidman EF, Mastro KA, Asiago-Reddy E, and Kufel WD. "Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection." Antimicrobial Agents and Chemotherapy 63, no. 6 (2019). https://doi.org/10.1128/AAC.00110-19.

MLA (9th ed.) Citation

MV, Beccari, et al. "Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection." Antimicrobial Agents and Chemotherapy, vol. 63, no. 6, 2019, https://doi.org/10.1128/AAC.00110-19.